124 related articles for article (PubMed ID: 33394687)
1. Evodiamine inhibits vasculogenic mimicry in HCT116 cells by suppressing hypoxia-inducible factor 1-alpha-mediated angiogenesis.
Zeng D; Zhou P; Jiang R; Li XP; Huang SY; Li DY; Li GL; Li LS; Zhao S; Hu L; Ran JH; Chen DL; Wang YP; Li J
Anticancer Drugs; 2021 Mar; 32(3):314-322. PubMed ID: 33394687
[TBL] [Abstract][Full Text] [Related]
2. Hypoxia promotes vasculogenic mimicry formation by vascular endothelial growth factor A mediating epithelial-mesenchymal transition in salivary adenoid cystic carcinoma.
Wang HF; Wang SS; Zheng M; Dai LL; Wang K; Gao XL; Cao MX; Yu XH; Pang X; Zhang M; Wu JB; Wu JS; Yang X; Tang YJ; Chen Y; Tang YL; Liang XH
Cell Prolif; 2019 May; 52(3):e12600. PubMed ID: 30945361
[TBL] [Abstract][Full Text] [Related]
3. Yi Ai Fang, a traditional Chinese herbal formula, impacts the vasculogenic mimicry formation of human colorectal cancer through HIF-1α and epithelial mesenchymal transition.
Hou F; Li W; Shi Q; Li H; Liu S; Zong S; Ren J; Chai J; Xu J
BMC Complement Altern Med; 2016 Nov; 16(1):428. PubMed ID: 27806701
[TBL] [Abstract][Full Text] [Related]
4. HIF-1α induces VE-cadherin expression and modulates vasculogenic mimicry in esophageal carcinoma cells.
Tang NN; Zhu H; Zhang HJ; Zhang WF; Jin HL; Wang L; Wang P; He GJ; Hao B; Shi RH
World J Gastroenterol; 2014 Dec; 20(47):17894-904. PubMed ID: 25548487
[TBL] [Abstract][Full Text] [Related]
5. Induction of lncRNA NORAD accounts for hypoxia-induced chemoresistance and vasculogenic mimicry in colorectal cancer by sponging the miR-495-3p/ hypoxia-inducible factor-1α (HIF-1α).
Zhang L; Wu H; Zhang Y; Xiao X; Chu F; Zhang L
Bioengineered; 2022 Jan; 13(1):950-962. PubMed ID: 34969360
[TBL] [Abstract][Full Text] [Related]
6. Inhibitory effects of compound DMBT on hypoxia-induced vasculogenic mimicry in human breast cancer.
Li S; Zhang Q; Zhou L; Guan Y; Chen S; Zhang Y; Han X
Biomed Pharmacother; 2017 Dec; 96():982-992. PubMed ID: 29208325
[TBL] [Abstract][Full Text] [Related]
7. Hypoxia-induced vasculogenic mimicry formation in human colorectal cancer cells: Involvement of HIF-1a, Claudin-4, and E-cadherin and Vimentin.
Li W; Zong S; Shi Q; Li H; Xu J; Hou F
Sci Rep; 2016 Nov; 6():37534. PubMed ID: 27869227
[TBL] [Abstract][Full Text] [Related]
8. Hypoxia promotes vasculogenic mimicry formation by inducing epithelial-mesenchymal transition in ovarian carcinoma.
Du J; Sun B; Zhao X; Gu Q; Dong X; Mo J; Sun T; Wang J; Sun R; Liu Y
Gynecol Oncol; 2014 Jun; 133(3):575-83. PubMed ID: 24589413
[TBL] [Abstract][Full Text] [Related]
9. Anti-angiogenic treatment promotes triple-negative breast cancer invasion via vasculogenic mimicry.
Sun H; Zhang D; Yao Z; Lin X; Liu J; Gu Q; Dong X; Liu F; Wang Y; Yao N; Cheng S; Li L; Sun S
Cancer Biol Ther; 2017 Apr; 18(4):205-213. PubMed ID: 28278077
[TBL] [Abstract][Full Text] [Related]
10. Jianpi Jiedu decoction, a traditional Chinese medicine formula, inhibits tumorigenesis, metastasis, and angiogenesis through the mTOR/HIF-1α/VEGF pathway.
Peng W; Zhang S; Zhang Z; Xu P; Mao D; Huang S; Chen B; Zhang C; Zhang S
J Ethnopharmacol; 2018 Oct; 224():140-148. PubMed ID: 29852266
[TBL] [Abstract][Full Text] [Related]
11. HIF-2α promotes the formation of vasculogenic mimicry in pancreatic cancer by regulating the binding of Twist1 to the VE-cadherin promoter.
Yang J; Zhu DM; Zhou XG; Yin N; Zhang Y; Zhang ZX; Li DC; Zhou J
Oncotarget; 2017 Jul; 8(29):47801-47815. PubMed ID: 28599281
[TBL] [Abstract][Full Text] [Related]
12. Inhibitory effect of melatonin on hypoxia-induced vasculogenic mimicry via suppressing epithelial-mesenchymal transition (EMT) in breast cancer stem cells.
Maroufi NF; Amiri M; Dizaji BF; Vahedian V; Akbarzadeh M; Roshanravan N; Haiaty S; Nouri M; Rashidi MR
Eur J Pharmacol; 2020 Aug; 881():173282. PubMed ID: 32580038
[TBL] [Abstract][Full Text] [Related]
13. Tumor-expressed B7-H3 promotes vasculogenic mimicry formation rather than angiogenesis in non-small cell lung cancer.
Fan X; Huang J; Hu B; Zhou J; Chen L
J Cancer Res Clin Oncol; 2023 Sep; 149(11):8729-8741. PubMed ID: 37129607
[TBL] [Abstract][Full Text] [Related]
14. Plasticity of ovarian cancer cell SKOV3ip and vasculogenic mimicry in vivo.
Su M; Feng YJ; Yao LQ; Cheng MJ; Xu CJ; Huang Y; Zhao YQ; Jiang H
Int J Gynecol Cancer; 2008; 18(3):476-86. PubMed ID: 17645504
[TBL] [Abstract][Full Text] [Related]
15. TP53INP1 inhibits hypoxia-induced vasculogenic mimicry formation via the ROS/snail signalling axis in breast cancer.
Wang Y; Sun H; Zhang D; Fan D; Zhang Y; Dong X; Liu S; Yang Z; Ni C; Li Y; Liu F; Zhao X
J Cell Mol Med; 2018 Jul; 22(7):3475-3488. PubMed ID: 29655255
[TBL] [Abstract][Full Text] [Related]
16. BMP9 mediates the anticancer activity of evodiamine through HIF‑1α/p53 in human colon cancer cells.
Li FS; Huang J; Cui MZ; Zeng JR; Li PP; Li L; Deng Y; Hu Y; He BC; Shu DZ
Oncol Rep; 2020 Feb; 43(2):415-426. PubMed ID: 31894286
[TBL] [Abstract][Full Text] [Related]
17. HIF-1α promoted vasculogenic mimicry formation in lung adenocarcinoma through NRP1 upregulation in the hypoxic tumor microenvironment.
Fu R; Du W; Ding Z; Wang Y; Li Y; Zhu J; Zeng Y; Zheng Y; Liu Z; Huang JA
Cell Death Dis; 2021 Apr; 12(4):394. PubMed ID: 33850110
[TBL] [Abstract][Full Text] [Related]
18. Silencing the autophagy-specific gene Beclin-1 contributes to attenuated hypoxia-induced vasculogenic mimicry formation in glioma.
Duan S
Cancer Biomark; 2018 Feb; 21(3):565-574. PubMed ID: 29278874
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of HIF-1α in primary gallbladder carcinoma and its relation to vasculogenic mimicry and unfavourable prognosis.
Sun W; Shen ZY; Zhang H; Fan YZ; Zhang WZ; Zhang JT; Lu XS; Ye C
Oncol Rep; 2012 Jun; 27(6):1990-2002. PubMed ID: 22470047
[TBL] [Abstract][Full Text] [Related]
20. Effect of Genistein on vasculogenic mimicry formation by human uveal melanoma cells.
Cong R; Sun Q; Yang L; Gu H; Zeng Y; Wang B
J Exp Clin Cancer Res; 2009 Sep; 28(1):124. PubMed ID: 19735546
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
